Switch to: Citations

References in:

Post-trial access to treatment: corporate best practices

SOMO Centre for Research on Multinational Corporations (2015)

Add references

You must login to add references.
  1. The Ethical Problems of the Open Label Extension Study.Kenneth Craig Micetich - 1996 - Cambridge Quarterly of Healthcare Ethics 5 (3):410.
    The institutional review board Is charged with assessing the risks and benefits of research projects Involving human subjects. Ethical considerations and federal regulations require that an IRB, in part, must find that the potential risks of participation are proportional to the potential benefits and to the Importance of the knowledge that may be learned before the IRB can approve the voluntary assumption of risk by a research participant. Adequate assessment of the risks and benefits requires careful scrutiny of the study (...)
    Download  
     
    Export citation  
     
    Bookmark   3 citations  
  • Open-Label Extension Studies: Are They Really Research?Mildred K. Cho - 2014 - American Journal of Bioethics 14 (3):1-2.
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Open-Label Extension Studies: Are They Really Research?Mildred K. Cho - 2014 - American Journal of Bioethics 14 (4):60-61.
    Download  
     
    Export citation  
     
    Bookmark   1 citation